Veit Peter Grunert

1.4k total citations · 1 hit paper
9 papers, 994 citations indexed

About

Veit Peter Grunert is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Animal Science and Zoology. According to data from OpenAlex, Veit Peter Grunert has authored 9 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Animal Science and Zoology. Recurrent topics in Veit Peter Grunert's work include SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Veit Peter Grunert is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Veit Peter Grunert collaborates with scholars based in Germany, United States and Switzerland. Veit Peter Grunert's co-authors include R. von Kries, Erika von Mutius, Berthold Koletzko, Hubertus von Voß, T. Sauerwald, M. Hermann, Michael Soyka, Ingrid Domke, Sophia Horster and U Schiemann and has published in prestigious journals such as Frontiers in Immunology, Addiction and Allergy.

In The Last Decade

Veit Peter Grunert

9 papers receiving 899 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Breast feeding and obesity: cross sectional study

1999 631 citations R. von Kries, Berthold Koletzko et al. BMJ profile →

Peers

Countries citing papers authored by Veit Peter Grunert

Since Specialization

Citations

This map shows the geographic impact of Veit Peter Grunert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veit Peter Grunert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veit Peter Grunert more than expected).

Fields of papers citing papers by Veit Peter Grunert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veit Peter Grunert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veit Peter Grunert. The network helps show where Veit Peter Grunert may publish in the future.

Co-authorship network of co-authors of Veit Peter Grunert

This figure shows the co-authorship network connecting the top 25 collaborators of Veit Peter Grunert. A scholar is included among the top collaborators of Veit Peter Grunert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veit Peter Grunert. Veit Peter Grunert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial 2022 ·Frontiers in Immunology ·Simon Jochum, (unknown), (unknown), Veit Peter Grunert, Holly Legault, Udo Eichenlaub, (unknown), Rolando Pajón	39
2	Quantifying the Vaccine-Induced Humoral Immune Response to Spike-Receptor Binding Domain as a Surrogate for Neutralization Testing Following mRNA-1273 (Spikevax) Vaccination Against COVID-19 2022 ·Infectious Diseases and Therapy ·(unknown), (unknown), Veit Peter Grunert, Holly Legault, Maha Maglinao, Udo Eichenlaub, (unknown), Rolando Pajón, Simon Jochum	5
3	The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure 2013 ·Lara D. Veeken ·(unknown), Veit Peter Grunert, Merete Lund Hetland, Julia S. Johansen, (unknown), Giuseppe Palermo, Laurent Essioux, (unknown)	58
4	Classification of Therapy Resistance Based on Longitudinal Biomarker Profiles 2009 ·Biometrical Journal ·(unknown), Leonhard Held, Veit Peter Grunert	12
5	Diagnosis of rheumatoid arthritis: multivariate analysis of biomarkers 2008 ·Biomarkers ·Norbert Wild, Johann Karl, Veit Peter Grunert, (unknown), Ursula Garczarek, Friedemann Krause, F Hasler, Piet L. C. M. van Riel, Péter Bayer, (unknown), Derek L. Mattey, Mohammed Sharif, Werner Zolg	19
6	Validity of carbohydrate‐deficient transferrin (%CDT), γ‐glutamyltransferase (γ‐GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non‐alcoholic and alcoholic origin 2005 ·Addiction ·B. Hock, Markus Schwarz, Ingrid Domke, Veit Peter Grunert, (unknown), U Schiemann, Sophia Horster, (unknown), (unknown), Michael Soyka	94
7	Is obesity a risk factor for childhood asthma? 2001 ·Allergy ·R. von Kries, M. Hermann, Veit Peter Grunert, Erika von Mutius	132
8	PREVENTION OF CHILDHOOD LEUKEMIA BY BCG VACCINATION IN NEWBORNS? A POPULATION-BASED CASE-CONTROL STUDY IN LOWER SAXONY, GERMANY 2000 ·Pediatric Hematology and Oncology ·Rüdiger von Kries, Veit Peter Grunert, Uwe Kaletsch, J. Michaelis, U. Göbel	4
9	Breast feeding and obesity: cross sectional study breakdown → 1999 ·BMJ ·R. von Kries, Berthold Koletzko, T. Sauerwald, Erika von Mutius, (unknown), Veit Peter Grunert, Hubertus von Voß	631

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact